<DOC>
	<DOCNO>NCT02693210</DOCNO>
	<brief_summary>WA16291 Phase IIa `` proof-of-concept '' study . The primary objective study determine safety efficacy rituximab ( B cell deplete chimeric monoclonal antibody ) use either monotherapy combination methotrexate cyclophosphamide participant rheumatoid arthritis fail prior Disease Modifying Anti-Rheumatic Drug ( DMARD ) therapy currently inadequate clinical response methotrexate .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Mabthera Alone Combination With Either Cyclophosphamide Methotrexate Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Participants moderate severe rheumatoid arthritis ( RA ) previously fail 15 DMARDS currently partial clinical response treatment methotrexate Using methotrexate single DMARD least 16 week , last 4 week prior baseline stable oral dose great equal ( &gt; = ) 10 milligram per week ( mg/week ) &gt; =21 year age Swollen Joint Count ( SJC ) Tender Joint Count ( TJC ) &gt; = 8 ( 66 68 joint respectively ) At least 2 follow parameter Baseline : C Reactive Protein &gt; = 15 mg/dL ; Erythrocyte Sedimentation Rate &gt; = 30 millimeter per hour ( mm/hr ) ; Morning stiffness &gt; 45 minute Rheumatoid factor titer &gt; =20 International unit per milliliter ( IU/mL ) Corticosteroid ( less equal [ = &lt; ] 12.5 milligram per deciliter [ mg/d ] prednisone equivalent ) NonSteroidal AntiInflammatory Drugs ( NSAIDs ) permit stable least 4 week prior baseline American Rheumatism Association ( ARA ) Class IV RA disease Concurrent treatment DMARD ( apart randomize treatment ) antiTNFalpha therapy Active infection history recurrent significant infection Prior history cancer include solid tumor hematologic malignancy ( except basal carcinoma skin excise cure ) Evidence serious uncontrolled concomitant disease cardiovascular disease , nervous system , pulmonary , renal , hepatic , endocrine gastrointestinal disorder Bone/joint surgery within 6 week prior screen Rheumatic Autoimmune disease RA Active rheumatoid vasculitis Prior history gout Chronic fatigue syndrome</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>